Paleness and drugs of ingredients of regadenoson (a real world drug study)
Summary:
Paleness is found among people who take drugs with ingredients of regadenoson, especially for people who are male, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 4,785 people who have side effects when taking drugs with ingredients of regadenoson from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Lexiscan, Regadenoson.
4,785 people reported to have side effects when taking drugs with ingredients of regadenoson.
Among them, 33 people (0.69%) have Paleness
What is Paleness?
Paleness (unusual lightness of skin colour) is found to be associated with 1,562 drugs and 2,117 conditions by eHealthMe. Check the latest studies of Paleness.
Number of reports submitted per year:

Time on drugs with ingredients of regadenoson when people have Paleness *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Paleness when taking drugs with ingredients of regadenoson *:
- female: 40.62 %
- male: 59.38 %
Age of people who have Paleness when taking drugs with ingredients of regadenoson *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 8.33 %
- 40-49: 0.0 %
- 50-59: 8.33 %
- 60+: 83.33 %
Conditions people have *:
You may use this to check any potential undetected conditions.
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 6.06%
Other drugs people take *:
You may use this to check any potential interacting drugs.
- Aspirin: 4 people, 12.12%
- Metoprolol Tartrate: 4 people, 12.12%
- Novolog: 2 people, 6.06%
- Detrol: 2 people, 6.06%
- Furosemide: 2 people, 6.06%
- Lasix: 2 people, 6.06%
- Levemir: 2 people, 6.06%
- Levoxyl: 2 people, 6.06%
- Celexa: 2 people, 6.06%
- Loratadine: 2 people, 6.06%
Other side effects people have besides Paleness *:
You may use this to check any potential undetected side effects.
- Hypotension (abnormally low blood pressure): 17 people, 51.52%
- Dizziness: 11 people, 33.33%
- Hyperhidrosis (abnormally increased sweating): 9 people, 27.27%
- Nausea (feeling of having an urge to vomit): 9 people, 27.27%
- Dyspnea (difficult or laboured breathing): 7 people, 21.21%
- Heart Rate Decreased: 6 people, 18.18%
- Fainting (loss of consciousness and postural tone): 6 people, 18.18%
- Chest Pain: 5 people, 15.15%
- Bradycardia (abnormally slow heart action): 4 people, 12.12%
- Skin - Clammy: 4 people, 12.12%
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drugs with ingredients of regadenoson, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on regadenoson. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cleocin cause Tumor? - 11 seconds ago
- Could Antara cause White Blood Cell Count Decreased? - 27 seconds ago
- Scoliosis and drugs of ingredients of abatacept - 30 seconds ago
- Vancomycin and Zometa drug interactions for men aged 60+ - 37 seconds ago
- Could Q10 cause Bruxism? - 40 seconds ago
- Biotin and Actinic Keratosis for Women aged 50-59 - 47 seconds ago
- Biotin and Solar Keratosis for Women aged 50-59 - 48 seconds ago
- Biotin and Keratosis - Actinic (Solar) for Women aged 50-59 - 48 seconds ago
- Biotin and Sun-Induced Skin Changes - Keratosis for Women aged 50-59 - 48 seconds ago
- Drug interactions of Sumatriptan Succinate and Olive Leaf - 49 seconds ago